NEW YORK (GenomeWeb News) – Cell Biosciences said today that it has acquired sample-prep company Protein Forest in an all-stock transaction worth an undisclosed amount.

In addition, Cell Biosciences said that in connection with the acquisition, it has raised an additional $4 million in equity financing, led by Novo A/S.

The acquisition adds Protein Forest's digital ProteomeChip product, including instrumentation, software, reagents, and consumables, to Santa Clara, Calif.-based Cell Biosciences' portfolio of protein-analysis products.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.